Global Ganja Report

Growing numbers around the United States and the world are using cannabis to treat a wide spectrum of medical conditions, and legal space is widening for them to do so. So it's a particular irony that hospitals as a rule bar cannabis from their premises. More voices in the medical industry are now grappling with this dilemma.

Voters in New Jersey will decide whether to legalize cannabis in the Garden State next year. A measure approved by both houses of the state Legislature officially places the question on the 2020 ballot—ending long months of inaction on a promised legalization bill.

The Chicago suburb of Evanston has become the first city in the United States to put revenues from legal cannabis sales into a "reparations" fund for the city's African American residents—seeking to redress harms not only from the war on drugs but a greater matrix of social injustice.

Legal cannabis sales are officially starting in Michigan on Dec. 1—but with a big emphasis on the "officially." Cannabis shortages and a dearth of licensed dispensaries mean that the Wolverine State's retail recreational program will be off to a less than flying start. Even last-minute abandonment of the planned firewall between the medical and recreational markets may be insufficient to salvage the situation.

California is moving toward adopting official "appellations" for cannabis, certifying a strain's regional origin. The concept is inspired by the wine industry, where such a certification system has long been in place in several producer countries. Wine appellations, often a mark of prestige, provide a model for what is now to be applied to high-end cannabis.

The percentage of military veterans facing challenges from PTSD is staggering, but the Department of Veterans Affairs remains intransigent on allowing access to cannabis—the only treatment that provides relief for many. And there has been little progress on efforts in Congress to remedy the situation.

As a new law lifts restrictions on investment in Colorado's cannabis sector, many fear consolidation by big money—a concern uniting some small operators with cultural conservatives. But others see a growth opportunity for small enterprises.

Hemp and hemp-derived CBD were officially legalized under the 2018 Farm Bill, but the US Department of Agriculture has failed to bring its regulations into conformity with the new federal law—until now. Interim regs have just been issued by the USDA, with a 60-day public comment period to follow—meaning a final rule will likely be in place in time for next year's planting season.